Pharmaceutical News

RSS

Genetic factors may increase person's risk for adverse effects of synthetic cannabinoids

Synthetic cannabinoid abuse is a growing problem in the United States, with new versions of the drugs coming on the market every year. New research is examining how the body processes these man-made drugs and the role that genetics might play in their metabolism.

25 Apr 2017

Brown University researchers develop new multi-reaction catalyst

Brown University researchers have developed a new composite catalyst that can perform four separate chemical reactions in sequential order and in one container to produce compounds useful in making a wide range of pharmaceutical products.

25 Apr 2017

Intraoperative methadone offers promise to reduce need for pain medications during recovery

Patients undergoing spinal fusion surgery who are treated with methadone during the procedure require significantly less intravenous and oral opioids to manage postoperative pain, reports a new study published in the May issue of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists.

24 Apr 2017

Statins may provide favorable outcomes to patients with HBV- or HCV-related cirrhosis

Infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) can lead to cirrhosis as well as liver cancer. A Hepatology study from Taiwan has found that statins may provide benefits to patients with HBV- or HCV-related cirrhosis.

24 Apr 2017

New model for toxicity risk assessment could reduce reliance on animal testing

Traditional toxicological investigations performed on animals (in vivo) are expensive, time-consuming and may cause animal suffering.

24 Apr 2017

Tiny silica 'cages' could help store and transport vaccines without refrigeration

Vaccines and antibodies could be transported and stored without refrigeration by capturing them in tiny silica 'cages', a discovery which could make getting vital medicines to remote or dangerous places much easier, cheaper and safer.

24 Apr 2017

Positive CHMP opinion recognizes efficacy of Biogen’s SPINRAZA for treatment of spinal muscular atrophy

Biogen today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending the granting of a marketing authorization for SPINRAZA to treat patients with spinal muscular atrophy (SMA).

21 Apr 2017

The Horizon unveiled at PEGS 2017 by Halo Labs

Halo Labs announces the launch of a novel low volume, high throughput biopharmaceutical particle analysis system called the Horizon at PEGS 2017 in Boston on May 1st. The new system analyzes sub visible particulate matter in biopharmaceutical samples to enable for the first time rapid particle screening as early as candidate selection and pre-formulation.

21 Apr 2017

Study finds increase in number of prescriptions filled for chronic conditions after Medicaid expansion

During the first one and a half years of the Affordable Care Act, the number of prescriptions filled by adults using Medicaid coverage increased by 19% in states that expanded Medicaid compared to states that did not, according to a new study from a Harvard T.H. Chan School of Public Health researcher and colleagues.

21 Apr 2017

Study finds higher state of consciousness under the influence of psychedelic drugs

The study led by the University of Sussex has revealed scientific evidence for a higher state of consciousness.

20 Apr 2017

Scientists develop new drug that combats two ‘priority pathogens’

Scientists at St. Boniface Hospital Albrechtsen Research Centre and the University of Manitoba have developed a drug that combats 2 of the top 10 "priority pathogens" recently defined by the World Health Organization as antiobiotic-resistant bacteria requiring new interventions.

20 Apr 2017

Use of stimulants may lead to psychomotor control deficits, study finds

Researchers have found that current or past use of methamphetamine or other stimulants may lead to psychomotor control deficits, or a reduced ability to control physical movement.

20 Apr 2017

Review finds no evidence that low- dose aspirin buffers against cognitive decline

An analysis of published studies found no evidence that low- dose aspirin buffers against cognitive decline or dementia or improves cognitive test scores.

20 Apr 2017

Use of inhaled steroids linked to increased pneumonia risk in asthma patients

Use of inhaled corticosteroids was linked with an increased risk of pneumonia in a study of individuals with asthma.

20 Apr 2017

Fungi have immense potential for production of pharmaceutical compounds

Fungi are a potential goldmine for the production of pharmaceuticals. This is shown by researchers at Chalmers University of Technology, who have developed a method for finding new antibiotics from nature's own resources.

20 Apr 2017

Drug created from malaria protein offers hope for bladder cancer patients

A drug created from a malaria protein stopped tumor growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments.

20 Apr 2017

Study shows evidence that old drug may provide relief for advanced Parkinson's disease patients

New research provides evidence that an old drug may provide relief for people with advanced Parkinson's, according to a study released today that will be presented at the American Academy of Neurology's 69th Annual Meeting in Boston, April 22 to 28, 2017.

20 Apr 2017

How physicians can prevent opioid abuse while providing adequate pain relief

Rather than being considered a miracle pill that magically takes away pain, prescription opioids are increasingly being seen as a precursor to heroin addiction and the cause of potentially deadly overdoses themselves.

19 Apr 2017

Brain cancer patient treated with malaria drug shows dramatic improvement

After her brain cancer became resistant to chemotherapy and then to targeted treatments, 26-year-old Lisa Rosendahl's doctors gave her only a few months to live.

19 Apr 2017

‘Geneva signature’ evaluates safety and immunogenicity of promising anti-Ebola virus vaccine

An international team based at Geneva University Hospitals and at the University of Geneva, Switzerland, has succeeded in defining a "signature" composed of a small number of inflammatory markers that can be monitored in order to understand how a promising anti-Ebola virus vaccine stimulates the immune system.

19 Apr 2017

Pharmaceutical News

Genetic factors may increase person's risk for adverse effects of synthetic cannabinoids

Brown University researchers develop new multi-reaction catalyst

Intraoperative methadone offers promise to reduce need for pain medications during recovery

Statins may provide favorable outcomes to patients with HBV- or HCV-related cirrhosis

New model for toxicity risk assessment could reduce reliance on animal testing

Tiny silica 'cages' could help store and transport vaccines without refrigeration

Positive CHMP opinion recognizes efficacy of Biogen’s SPINRAZA for treatment of spinal muscular atrophy

The Horizon unveiled at PEGS 2017 by Halo Labs

Study finds increase in number of prescriptions filled for chronic conditions after Medicaid expansion

Study finds higher state of consciousness under the influence of psychedelic drugs

Scientists develop new drug that combats two ‘priority pathogens’

Use of stimulants may lead to psychomotor control deficits, study finds

Review finds no evidence that low- dose aspirin buffers against cognitive decline

Use of inhaled steroids linked to increased pneumonia risk in asthma patients

Fungi have immense potential for production of pharmaceutical compounds

Drug created from malaria protein offers hope for bladder cancer patients

Study shows evidence that old drug may provide relief for advanced Parkinson's disease patients

How physicians can prevent opioid abuse while providing adequate pain relief

Brain cancer patient treated with malaria drug shows dramatic improvement

‘Geneva signature’ evaluates safety and immunogenicity of promising anti-Ebola virus vaccine

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News